Guides
Insurance Stopped Covering Your GLP-1? Your Real Options in 2026

Losing GLP-1 coverage mid-treatment has become one of the most common ways people end up off their medication — not a decision, just a benefits change that lands in January or at plan renewal. The letter says the formulary changed; what it means is that the route you were on has closed. Before you accept that the medication chapter is over, walk through the actual options in order — and if you do choose to stop, it goes far better done deliberately than by default.
Step 1: Make sure it’s really gone
- Ask whether the denial is a formulary exclusion or a prior-authorization lapse — PAs expire and can be renewed by your prescriber in days.
- Ask about step therapy: some plans still cover after documented tries of other options.
- If you have a diagnosis beyond weight (type 2 diabetes, sleep apnea), coverage often runs through a different, still-open door — worth an explicit conversation with your prescriber.
- Appeals exist and sometimes work, especially with a letter of medical necessity. Ask your provider’s office — they write these routinely.
Step 2: Price the cash options like a spreadsheet, not a sticker
If coverage is gone, the remaining routes are the brand manufacturers’ own self-pay programs and compounded GLP-1 medication prescribed by a licensed provider — a different, non-FDA-approved finished product that a provider may choose when clinically appropriate. Whichever route you look at, ask what the price is at the dose you will actually be on and whether there is a separate membership fee; our guide to hidden telehealth fees covers the membership-fee and dose-surcharge tricks. For the full menu of options in order, see our coverage guide.
Step 3: If you continue — don’t let the gap decide your dose
A coverage loss usually means switching how you get the medication, and the trap is being restarted at the starter dose as if your months of titration never happened. Any program worth paying asks what you were taking and where you left off, with a licensed provider building the plan from your history. The switching-without-starting-over guide covers exactly what to have ready.
Step 4: If you stop — stop on purpose
Some people take a coverage loss as the moment to come off, and that’s a legitimate choice — made deliberately. The biology is worth knowing going in: in trials, people who stopped regained roughly two-thirds of lost weight within a year, because the appetite the medication was quieting comes back. That’s not destiny, but it does mean maintenance needs a plan: a protein floor, resistance training, a weigh-in routine, and an early line back to a provider if the trend turns. Our guide to stopping tirzepatide covers the first ninety days, and maintenance dosing explains the lower-dose middle path many providers now use. If you are staying off for good, our guide to doing it without the rebound covers the maintenance window.
Keep reading
This article is for informational purposes only and does not constitute medical advice. Compounded tirzepatide is not FDA-approved. A licensed provider determines whether treatment is appropriate for you. Read how we source and review content and the references behind the clinical figures used on this site.